Preliminary Results of Stage 1 of the Phase 2a Study” authored by Drew W. Rasco (South Texas Accelerated Research Therapeutics, San Antonio, ...
News
- News review of 2 biotech stocks: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Seattle Genetics ...
- Texas Roundup: Azaya, StemBioSys, Next Coast, Querium, Favor, MacroFab
—San Antonio biotech Azaya Therapeutics has been bought by Cytori Therapeutics in San Diego. Azaya shareholders are receiving $2 million in ...
- We asked pharma executives the one question they didn't want to hear about drug pricing
Biotech and pharma stocks fell on the comments and haven't really recovered. Investors might fear that a tweet from the president attacking a company ...
- Homegrown tech startup accelerator aims to fill hole left by Techstars
Evans is also the director of the graduate school of biomedical sciences at the University of Texas Health Science Center at San Antonio. Chris Saum ...
- San Antonio the city of science, research, discovery?
Scientific achievements in the city remain underappreciated but is home to The University of Texas Health Science Center and the Texas Biomedical ...